Jain, Nimansha
Holtzman, David M.
Article History
Received: 16 February 2023
Accepted: 23 February 2023
First Online: 5 April 2023
Declarations
:
: Not applicable.
: Not applicable.
: D.M.H. is on the scientific advisory board of C2N Diagnostics and has equity. D.M.H. is on the scientific advisory board of Denali Therapeutics, Genentech, and Cajal Neuroscience and consults for Alector.